FDA Greenlights New Depression Treatment

The FDA is approving a new antidepressant for people with depression that is so bad no other treatments work. The nasal spray esketamine acts within hours and could help about five million Americans with major depressive disorder and have not been helped by traditional medication. It must be administered under medical supervision and must be given at a doctor's office or clinic.

The drug is a component of ketamine, which was once a party drug known as Special K.

 

title

Content Goes Here